In Vitro Activities of Garenoxacin (BMS-284756) against 170 Clinical Isolates of Nine Pasteurella Species
2002 ◽
Vol 46
(9)
◽
pp. 3068-3070
◽
Keyword(s):
ABSTRACT The in vitro susceptibilities of 170 clinical isolates plus 12 American Type Culture Collection strains of Pasteurella species comprising nine species and three Pasteurella multocida subspecies were studied by an agar dilution method. Garenoxacin (BMS-284756), a new des-fluoro(6) quinolone, was active at ≤0.06 μg/ml against all isolates, including four β-lactamase-producing strains, with >90% of the strains susceptible to ≤0.008 μg/ml. Garenoxacin was generally 1 to 2 dilutions more active than levofloxacin and moxifloxacin and was the most active agent tested. Cefoxitin required 1 μg/ml for inhibition of 51 of 182 (29%) of strains, and 3 strains (also β-lactamase producers) were resistant to doxycycline.
2006 ◽
Vol 50
(1)
◽
pp. 379-381
◽
Keyword(s):
1996 ◽
Vol 40
(6)
◽
pp. 1419-1421
◽
2002 ◽
Vol 46
(12)
◽
pp. 3995-3996
◽
Keyword(s):
2003 ◽
Vol 47
(6)
◽
pp. 1968-1971
◽
Keyword(s):
2013 ◽
Vol 59
(4)
◽
pp. 252-259
◽
2007 ◽
Vol 51
(8)
◽
pp. 2716-2719
◽
2001 ◽
Vol 45
(11)
◽
pp. 3205-3208
◽
2000 ◽
Vol 44
(9)
◽
pp. 2525-2529
◽
2006 ◽
Vol 24
(4)
◽
pp. 273-279
2015 ◽
Vol 2015
◽
pp. 1-10
◽